Stage IV Hypopharyngeal Squamous Cell Carcinoma
6 clinical trials · Condition
◉ Watch Stage IV Hypopharyngeal Squamous Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| Nivolumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma That Can Be Removed by Surgery (NCT03342911) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2017-11-13 |
| Cisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer (NCT02196168) | National Cancer Institute (NCI) | 2014-03-01 |
| Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy (NCT01256385) | National Cancer Institute (NCI) | 2010-11-01 |
| Soy Isoflavones in Preventing Head and Neck Cancer Recurrence in Patients With Stage I-IV Head and Neck Cancer Undergoing Surgery (NCT02007200) | National Cancer Institute (NCI) | 2009-07-01 |
| Cediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck Cancer (NCT00458978) | National Cancer Institute (NCI) | 2007-02-01 |
Track Stage IV Hypopharyngeal Squamous Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.